SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Vascular Collagen Type-IV in Hypertension and Cerebral Small Vessel Disease.

Kumar, AA; Yeo, N; Whittaker, M; Attra, P; Barrick, TR; Bridges, LR; Dickson, DW; Esiri, MM; Farris, CW; Graham, D; et al. Kumar, AA; Yeo, N; Whittaker, M; Attra, P; Barrick, TR; Bridges, LR; Dickson, DW; Esiri, MM; Farris, CW; Graham, D; Lin, WL; Meijles, DN; Pereira, AC; Perry, G; Rosene, DL; Shtaya, AB; Van Agtmael, T; Zamboni, G; Hainsworth, AH (2022) Vascular Collagen Type-IV in Hypertension and Cerebral Small Vessel Disease. Stroke, 53 (12). pp. 3696-3705. ISSN 1524-4628 https://doi.org/10.1161/STROKEAHA.122.037761
SGUL Authors: Hainsworth, Atticus Henry Barrick, Thomas Richard Meijles, Daniel Nathan

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (4MB) | Preview
[img]
Preview
PDF (Supplemental Publication Material) Published Version
Available under License Creative Commons Attribution.

Download (461kB) | Preview
[img]
Preview
PDF (ARRIVE Checklist) Published Version
Available under License Creative Commons Attribution.

Download (127kB) | Preview
[img]
Preview
PDF (STROBE Checklist) Published Version
Available under License Creative Commons Attribution.

Download (124kB) | Preview
[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution.

Download (165kB)

Abstract

BACKGROUND: Cerebral small vessel disease (SVD) is common in older people and causes lacunar stroke and vascular cognitive impairment. Risk factors include old age, hypertension and variants in the genes COL4A1/COL4A2 encoding collagen alpha-1(IV) and alpha-2(IV), here termed collagen-IV, which are core components of the basement membrane. We tested the hypothesis that increased vascular collagen-IV associates with clinical hypertension and with SVD in older persons and with chronic hypertension in young and aged primates and genetically hypertensive rats. METHODS: We quantified vascular collagen-IV immunolabeling in small arteries in a cohort of older persons with minimal Alzheimer's pathology (N=52; 21F/31M, age 82.8±6.95 years). We also studied archive tissue from young (age range 6.2-8.3 years) and older (17.0-22.7 years) primates (M mulatta) and compared chronically hypertensive animals (18 months aortic stenosis) with normotensives. We also compared genetically hypertensive and normotensive rats (aged 10-12 months). RESULTS: Collagen-IV immunolabeling in cerebral small arteries of older persons was negatively associated with radiological SVD severity (ρ: -0.427, P=0.005) but was not related to history of hypertension. General linear models confirmed the negative association of lower collagen-IV with radiological SVD (P<0.017), including age as a covariate and either clinical hypertension (P<0.030) or neuropathological SVD diagnosis (P<0.022) as fixed factors. Reduced vascular collagen-IV was accompanied by accumulation of fibrillar collagens (types I and III) as indicated by immunogold electron microscopy. In young and aged primates, brain collagen-IV was elevated in older normotensive relative to young normotensive animals (P=0.029) but was not associated with hypertension. Genetically hypertensive rats did not differ from normotensive rats in terms of arterial collagen-IV. CONCLUSIONS: Our cross-species data provide novel insight into sporadic SVD pathogenesis, supporting insufficient (rather than excessive) arterial collagen-IV in SVD, accompanied by matrix remodeling with elevated fibrillar collagen deposition. They also indicate that hypertension, a major risk factor for SVD, does not act by causing accumulation of brain vascular collagen-IV.

Item Type: Article
Additional Information: © 2022 The Authors. Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Keywords: Alzheimer disease, animals, collagen, hypertension, linear models, 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, 1109 Neurosciences, Neurology & Neurosurgery
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Stroke
ISSN: 1524-4628
Language: eng
Dates:
DateEvent
December 2022Published
7 October 2022Published Online
31 August 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
204809/Z/16/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
G1000691Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
PG146/151Alzheimer's Societyhttp://dx.doi.org/10.13039/501100000320
20140901Alzheimer's Drug Discovery Foundationhttp://dx.doi.org/10.13039/100002565
PPG2014A-8Alzheimer's Research UKUNSPECIFIED
MR/R005567/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
CL-2015-16-001National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
P01-NS40256-10National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
P50-AG16574-14National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
P50-AG2571105National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
P01-AG000001National Institute on Aginghttp://dx.doi.org/10.13039/100000049
P01-NS031649National Institute of Neurological Disorders and Strokehttp://dx.doi.org/10.13039/100000065
16VAD-04Stroke Associationhttp://dx.doi.org/10.13039/501100000364
RG 2664/17/20Heart Research UKhttp://dx.doi.org/10.13039/501100000327
PubMed ID: 36205142
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114873
Publisher's version: https://doi.org/10.1161/STROKEAHA.122.037761

Actions (login required)

Edit Item Edit Item